{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:54:25Z","timestamp":1783612465326,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijid.2020.01.021","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T12:17:29Z","timestamp":1579609049000},"page":"241-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene"],"prefix":"10.1016","volume":"92","author":[{"given":"Fengmin","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-9807","authenticated-orcid":false,"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijid.2020.01.021_bib0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1369-5274(99)00005-3","article-title":"The biological cost of antibiotic resistance","volume":"2","author":"Andersson","year":"1999","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"10.1016\/j.ijid.2020.01.021_bib0010","first-page":"21","article-title":"Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes","volume":"41","author":"Canetti","year":"1969","journal-title":"Bull World Health Organ"},{"issue":"11","key":"10.1016\/j.ijid.2020.01.021_bib0015","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1128\/AAC.00541-09","article-title":"Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam","volume":"53","author":"Duong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2020.01.021_bib0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes","volume":"42","author":"Falzon","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ijid.2020.01.021_bib0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.ijid.2020.01.021_bib0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1473-3099(03)00671-6","article-title":"Fluoroquinolones, tuberculosis, and resistance","volume":"3","author":"Ginsburg","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2020.01.021_bib0035","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1128\/AAC.49.3.1229-1231.2005","article-title":"Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany","volume":"49","author":"Hillemann","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2020.01.021_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02303-17","article-title":"A 10-year comparative analysis shows that increasing prevalence of rifampin-resistant Mycobacterium tuberculosis in China is associated with the transmission of strains harboring compensatory mutations","volume":"62","author":"Huo","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.01.021_bib0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jprot.2015.07.031","article-title":"Proteomic analysis of ofloxacin-mono resistant Mycobacterium tuberculosis isolates","volume":"127","author":"Lata","year":"2015","journal-title":"J Proteomics"},{"issue":"4","key":"10.1016\/j.ijid.2020.01.021_bib0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2174\/0929866522666150209113708","article-title":"Proteome analysis of ofloxacin and moxifloxacin induced Mycobacterium tuberculosis isolates by proteomic approach","volume":"22","author":"Lata","year":"2015","journal-title":"Protein Pept Lett"},{"issue":"3","key":"10.1016\/j.ijid.2020.01.021_bib0055","first-page":"e19","article-title":"Association of gyrA\/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis","volume":"3","author":"Li","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijid.2020.01.021_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1083","article-title":"China\u2019s misuse of antibiotics should be curbed","volume":"348","author":"Li","year":"2014","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ijid.2020.01.021_bib0065","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1469-0691.2007.01711.x","article-title":"Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia","volume":"13","author":"Lipin","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.ijid.2020.01.021_bib0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrg3351","article-title":"Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance","volume":"14","author":"Palmer","year":"2013","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ijid.2020.01.021_bib0075","doi-asserted-by":"crossref","first-page":"25330","DOI":"10.1038\/srep25330","article-title":"Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China","volume":"6","author":"Pang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2020.01.021_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2017.08.005","article-title":"Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the national clinical center for tuberculosis in china: a five-year review","author":"Pang","year":"2017","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.ijid.2020.01.021_bib0085","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01429-2016","article-title":"Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study","volume":"49","author":"Pang","year":"2017","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ijid.2020.01.021_bib0090","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02170-16","article-title":"Genotyping and prevalence of pyrazinamide- and moxifloxacin-resistant tuberculosis in China, 2000 to 2010","volume":"61","author":"Pang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2020.01.021_bib0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1473-3099(09)70330-5","article-title":"Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains","volume":"10","author":"Parwati","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2020.01.021_bib0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jac\/dkv360","article-title":"Specific gyrA gene mutations predict poor treatment outcome in MDR-TB","volume":"71","author":"Rigouts","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2020.01.021_bib0105","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1038\/s41598-017-10018-5","article-title":"Evolutionary pathway analysis and unified classification of East Asian lineage of Mycobacterium tuberculosis","volume":"7","author":"Shitikov","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2020.01.021_bib0110","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1128\/JCM.01257-15","article-title":"Diagnostic performance of the new version (v2.0) of genotype MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study","volume":"53","author":"Tagliani","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ijid.2020.01.021_bib0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmi.2016.10.022","article-title":"Mycobacterium tuberculosis drug resistance testing: challenges, recent developments and perspectives","volume":"23","author":"Sch\u00f6n","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2020.01.021_bib0120","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1093\/cid\/ciw012","article-title":"Infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key","volume":"62","author":"Van Cutsem","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.01.021_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciu209","article-title":"Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death","volume":"59","author":"Velasquez","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2020.01.021_bib0130","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1128\/AAC.00662-15","article-title":"Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis","volume":"59","author":"Willby","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.01.021_bib0135","series-title":"Global tuberculosis report 2018","author":"World Health Organization","year":"2018"},{"issue":"4","key":"10.1016\/j.ijid.2020.01.021_bib0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jinf.2017.12.017","article-title":"Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China","volume":"76","author":"Xu","year":"2018","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.ijid.2020.01.021_bib0145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jinf.2010.05.001","article-title":"Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China","volume":"61","author":"Yin","year":"2010","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.ijid.2020.01.021_bib0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jinf.2014.11.008","article-title":"Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China","volume":"70","author":"Zhang","year":"2015","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.ijid.2020.01.021_bib0155","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/AAC.01228-13","article-title":"Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China","volume":"58","author":"Zhang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2020.01.021_bib0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijantimicag.2013.12.007","article-title":"Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China","volume":"43","author":"Zhang","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"23","key":"10.1016\/j.ijid.2020.01.021_bib0165","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","article-title":"National survey of drug-resistant tuberculosis in China","volume":"366","author":"Zhao","year":"2012","journal-title":"N Engld J Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220300230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220300230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:50:14Z","timestamp":1761119414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220300230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":33,"alternative-id":["S1201971220300230"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.01.021","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}